8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Join Shaheen Limbada, EVP Innovation & Strategy at Veristat, and Dr. Leen Kawas of Propel Bio Partners for a thought-provoking roundtable discussion on the latest trends and solutions in decentralized clinical trials.
As an executive in the biotech industry, you understand the challenges of running complex clinical trials. Patient participation and retention are crucial to the success of any trial, and decentralized solutions are becoming increasingly popular to address these challenges.
At this exclusive event, you'll have the opportunity to:
DATE: Wednesday, February 22, 2023
TIME: 11:30 am – 1:30 pm PT (lunch is included)
LOCATION: The Lighthouse restaurant Conference Room A - 685 Gateway Boulevard, South San Francisco, CA 94080
Shaheen Limbada
Executive Vice President, Innovation and Strategy
Veristat
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...